Jim Cramer Recommends Uranium Energy Corp., Warns Against Overreliance on Arcus Biosciences.

Thursday, Aug 14, 2025 8:11 am ET1min read

Jim Cramer recommends Uranium Energy Corp. (UEC) but advises not to "bank it all" on Arcus Biosciences (RCUS). Cramer likes nuclear energy, but warns against relying solely on Arcus. HC Wainwright analyst Heiko Ihle maintains Uranium Energy with a Buy rating and raised the price target to $12.75. Wells Fargo analyst Eva Fortea Verdejo maintained Arcus Biosciences with an Overweight rating and lowered the price target to $25.

Jim Cramer Recommends Uranium Energy Corp., Warns Against Overreliance on Arcus Biosciences.

Comments



Add a public comment...
No comments

No comments yet